Safety Alert

# Title Type of news Date Link of news
232 Safety Signal of Octreotide and the Risk of Hyperkalaemia Signal
231 Safety Signal of Yellow Fever Vaccine and the Risk of Myocardial infarction Signal
230 Safety Signal of Venlafaxine and the Risk of Cardiac arrest Signal
229 Safety Signal of Semaglutide and the Risk of Sleep disorder Signal
228 Safety Signals Identified by SFDA (October - December) 2025 Signal
227 Safety Signal of Onasemnogene Abeparvovec and the Risk of Pneumonia Signal
226 Safety Signal of Liraglutide and the Risk of Hepatocellular Carcinoma Signal
225 Safety Signal of Dulaglutide and the Risk of Sleep Disorder Signal
224 Safety Signal of Desogestrel and the Risk of Meningioma Signal
223 Safety Signal of Daratumumab and the Risk of Conjunctivitis Signal
Displaying 11 - 20 of 244